Clinical Trials Logo

Clinical Trial Summary

This is a multicentre, randomised, double-blind, placebo-controlled, 4-way cross-over study. At each study visit a standardised treadmill test will be performed to provoke EIA. Before and after the challenge test pulmonary function variables (e.g. forced expiratory volume in one second (FEV1)) will be measured in order to assess the protective effect of the study medication.


Clinical Trial Description

- Primary objective: to demonstrate superiority of the protective effect of the fixed combination of disodium cromoglycate (DSCG) plus reproterol in comparison to the single component reproterol in adults suffering from exercise induced asthma (EIA). - Secondary objectives: to demonstrate superiority of the protective effect of DSCG plus reproterol in comparison to the single component DSCG; to demonstrate superiority of the protective effect of each single component in comparison to placebo. In addition, the tolerability of medications will be documented. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00777348
Study type Interventional
Source Viatris Inc.
Contact
Status Completed
Phase Phase 2
Start date November 2007
Completion date October 2008

See also
  Status Clinical Trial Phase
Completed NCT04302610 - Do Heat and Moisture Exchange Mask Reduce EIB and Cough Severity in Asthma N/A
Completed NCT00664937 - Exercise Induced Bronchoconstriction (0476-359) Phase 1
Completed NCT00090142 - Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275) Phase 3
Completed NCT03840044 - The Effect of Physical Exercise in a Cold Air Environment on Normal Volunteers and Asthmatic Patients N/A
Completed NCT00092131 - Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) Phase 3
Recruiting NCT05105529 - Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction N/A
Recruiting NCT06245551 - A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma Phase 3
Not yet recruiting NCT03327701 - The Effect of Benralizumab on Exercise-induced Bronchoconstriction Phase 3
Completed NCT00245570 - Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) Phase 3
Recruiting NCT00916773 - Pulmonary Disorders During Exercise in Patients With Obstructive Sleep Apnea N/A